N/A
N=74
The Effectiveness of a Physiotherapy Technique in Patients With Chronic Myofascial Temporomandibular Disorder
Myofascial Pain Syndrome · Temporomandibular Disorder
Bottom Line
View on ClinicalTrials.gov: NCT03619889 ↗Enrolled (actual)
74
Serious AEs
—
Results posted
Oct 2019
Primary outcome: Primary: Changes of Perceived Pain Between Three Time Points (Baseline, Post-treatment, and 3 Months Later) and Between Groups (Sham Simulation and Pressure Release Technique) — -1.03; -2.30; -0.77; -2.84 units on a scale — p=<0.001
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Manual pressure release technique on trigger points. (Other); Sham (Other)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Universidad Complutense de Madrid
- Primary completion
- Apr 2017
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Changes of Perceived Pain Between Three Time Points (Baseline, Post-treatment, and 3 Months Later) and Between Groups (Sham Simulation and Pressure Release Technique) |
-1.03; -2.30; -0.77; -2.84; 0.26; -0.54 | <0.001 sig |
| SECONDARY Changes of Pain Pressure Thresholds Anterior Temporalis |
-0.21; -0.48; -0.12; -0.40; 0.09; 0.08 | — |
| SECONDARY Changes in the Range of the Opening of the Mouth |
-0.26; -4.27; -1.09; -5.22; -0.83; -0.95 | — |
| SECONDARY Changes in the Neck Disability |
1.09; 5.78; 0.40; 5.40; -0.69; -0.38 | — |
| SECONDARY Changes in the Kinesiophobia |
1.80; 5.24; 1.83; 5.92; 0.03; 0.68 | — |
| SECONDARY Changes in the Catastrophizing |
2.14; 9.92; 0.80; 9.84; -1.34; -0.08 | — |
| SECONDARY Changes in the State Anxiety |
0.30; 1.59; 0.22; 1.53; -0.08; -0.05 | — |
| SECONDARY Changes in the State Depression |
0.25; 0.74; 0.10; 0.75; -0.15; 0.01 | <0.001 sig |
| SECONDARY Changes in the Trait Anxiety |
-0.02; 0.68; -0.22; 0.59; -0.20; -0.09 | — |
| SECONDARY Changes in the Trait Depression |
0.15; 0.30; 0.07; 0.36; -0.07; 0.06 | — |
| SECONDARY Changes of Pain Pressure Thresholds Upper Trapezius |
-0.21; -0.48; -0.12; -0.40; 0.09; 0.08 | — |
| SECONDARY Changes of Pain Pressure Thresholds Sternal Sternocleidomastoid |
-0.14; -0.22; -0.08; -0.33; 0.06; -0.11 | — |
| SECONDARY Changes of Pain Pressure Thresholds Superficial Masseter |
-0.23; -0.28; -0.21; -0.36; 0.02; -0.09 | — |
Summary
Participants with chronic orofacial pain caused by masticatory and neck muscles will be distributed in two groups, both followed with the same occlusal and self-care treatment. The experimental group will receive 5 sessions of physiotherapy applying a specific pressure on the trigger points while the control group will receive placebo through a simulation of the same technique. Orofacial perceived pain, pain pressure thresholds, catastrophizing, kinesiophobia, cervical disability, depression and anxiety will be evaluated at baseline, immediately after treatment and 3 months later.
Eligibility Criteria
Inclusion Criteria
- Patients ≥18 years.
- Patients diagnosed of myofascial TMD with at least one TrP with referred pain.
- TMD patients with a current complaint of myofascial pain with more than 6 months of evolution.
- Patients with myofascial TMD initially treated with splint currently used, that has not been modified in the last 6 months, without improvement.
Exclusion Criteria
- Patients treated with occlusal splint recently modified.
- Patients with acute TMJ diseases.
- Patients with systemic disease, neurological and muscular diseases.
- Patients with psychiatric or psychological disorders.
- Patients with cervical disc hernia and acute whiplash injury.
- Changes in the painkillers intake during the experiment.
Data sourced from ClinicalTrials.gov (NCT03619889). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.